A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)

NCT07794774 · clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
197
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer